비교리스트

 카트 문의
시장보고서
상품코드
1422168

말 헬스케어 시장 - 성장, 향후 전망, 경쟁 분석(2023-2031년)

Equine Healthcare Market - Growth, Future Prospects and Competitive Analysis, 2023 - 2031
발행일: | 리서치사: Acute Market Reports | 페이지 정보: 영문 118 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

말 헬스케어 시장은 예방적 건강관리 대책, 진단 및 치료의 발전, 승마 스포츠 및 레크리에이션에 대한 관심 증가 등 주요 촉진요인으로 인해 2024-2032년 예측 기간 동안 연평균 6.1%의 성장률을 기록할 것으로 예상됩니다. 그러나 비용과 접근성 문제가 제약 요인으로 작용하고 있습니다. 시장 세분화는 특정 제품 카테고리와 적응증의 우위를 강조하고, 지리적 동향은 시장 역학의 지역적 차이를 강조합니다. 경쟁 환경은 이 역동적인 시장을 극복하고 새로운 기회를 활용하기 위한 주요 기업들의 전략적 노력을 강조하고 있습니다. 말 헬스케어 시장에서 지속적인 성공을 거두기 위해서는 산업이 발전함에 따라 접근성 문제를 해결하고 혁신을 촉진하는 것이 매우 중요합니다.

예방적 헬스케어에 대한 중요성 증대

말의 예방적 건강관리에 대한 관심이 높아지면서 말 헬스케어 시장이 눈에 띄게 성장하고 있습니다. 말의 질병을 예방하고 전반적인 건강을 유지하기 위해 백신과 약용 사료 첨가제의 중요성을 인식하고 있는 말 소유주와 관리자들이 증가하고 있습니다. 이러한 추세는 말 사회에서 예방적 건강 관리의 채택이 크게 증가하고 있는 것으로도 알 수 있습니다.

진단과 치료의 발전

말 진단 및 의약품의 발전은 시장 성장에 크게 기여하고 있습니다. 근골격계 질환, 내과 질환, 말 헤르페스 바이러스 및 말 인플루엔자와 같은 바이러스 감염에 대한 고급 진단 도구와 효과적인 의약품의 개발로 말의 다양한 건강 상태를 진단하고 치료할 수 있는 능력이 향상되었습니다. 이러한 추세는 말의 수의학 진료에서 고급 진단과 의약품의 사용 증가로 입증되고 있습니다.

말의 스포츠와 레크리에이션에 대한 관심 증가

말의 스포츠 및 레크리에이션 활동의 인기가 높아짐에 따라 말의 특수한 요구에 맞는 건강 관리 제품 및 서비스에 대한 수요가 증가하고 있습니다. 여기에는 근골격계 질환 및 기생충 퇴치를 위한 전문 치료, 종합적인 건강 관리를 위한 소프트웨어 및 서비스 채택 등이 포함됩니다. 다양한 시장 경쟁과 레저 활동에 말의 참여가 증가하는 것도 시장 역학에 영향을 미치는 주요 요인입니다.

시장 억제요인

긍정적인 추세에도 불구하고 말 헬스케어 시장은 비용과 접근성 측면에서 뚜렷한 제약 요인에 직면해 있습니다. 특히 말 헬스케어 자원에 대한 접근성이 제한된 지역에서는 고급 진단, 의약품 및 전문 의료 서비스의 높은 비용으로 인해 말 소유주들이 어려움을 겪고 있습니다. 이러한 제약은 말 사회의 특정 부문에서 첨단 의료 솔루션의 보급을 가로막고 있습니다.

제품별 시장 분석 : 의약품이 시장을 독식

말 헬스케어 시장은 백신, 의약품, 의약품 사료 첨가제, 진단, 소프트웨어 및 서비스, 기타로 구분되며, 2023년에는 다양한 말의 건강 상태에 대한 효과적인 치료법에 대한 수요에 힘입어 의약품이 가장 높은 수익을 창출했습니다. 그러나 예측 기간(2024-2032년) 동안 가장 높은 CAGR을 기록한 분야는 소프트웨어 및 서비스 부문입니다. 이는 말 헬스케어 시스템이 말의 복지 전반에 필수적인 요소로 자리 잡았기 때문입니다.

적응증별 시장 세분화: 근골격계 질환과 기생충 퇴치가 시장을 장악

적응증별 세분화에는 근골격계 질환, 기생충 구제, 내과, 말 헤르페스 바이러스, 말 뇌척수염, 말 인플루엔자, 웨스트 나일 바이러스, 파상풍, 기타가 포함되며, 2023년에는 근골격계 질환과 기생충 구제 부문이 가장 높은 수익을 기록했습니다. 그러나 예측 기간 동안 가장 높은 CAGR을 기록한 분야는 말 헤르페스 바이러스와 말 인플루엔자 분야로, 말 사회의 건강 우선 순위가 바뀌고 있음을 보여줍니다.

북미, 세계 리더의 자리를 유지

말 헬스케어 시장은 지역별로 수익 기여도와 CAGR이 다르며, 다양한 지역적 추세를 보이고 있습니다. 북미는 잘 확립된 승마 산업과 말 헬스케어에 대한 높은 인식으로 인해 2023년 가장 높은 수익을 창출하는 지역으로 부상했습니다. 그러나 예측 기간 동안 가장 높은 CAGR을 보일 것으로 예상되는 지역은 아시아태평양입니다. 이는 아시아태평양의 승마 스포츠 및 레크리에이션에 대한 관심 증가와 말 건강에 대한 관심 증가를 반영합니다.

예측 기간 동안 시장 경쟁은 더욱 치열해질 것

말 헬스케어 시장은 Zoetis Inc., Boehringer Ingelheim, Merck & Co. Laboratories, Inc., Dechra Pharmaceuticals PLC 등 주요 기업들의 치열한 경쟁이 특징입니다. 이들 기업은 제품 혁신, 제휴, 인수 등의 전략을 채택하여 시장에서의 입지를 강화하고 있으며, 2023년 이들 기업의 총 시장 수익은 [실제 수익 수치 제공]이며, 2024년부터 2032년까지 예측 기간 동안 증가할 것으로 예상됩니다.

목차

제1장 서문

  • 보고서 내용
    • 보고서 목적
    • 대상자
    • 주요 제공 상품
  • 시장 세분화
  • 조사 방법
    • 단계 I - 2차 조사
    • 단계 II - 1차 조사
    • 단계 III - 전문가 패널 리뷰
    • 가정
    • 채용한 접근법

제2장 주요 요약

제3장 말 헬스케어 시장 : 경쟁 분석

  • 주요 벤더의 시장에서의 포지셔닝
  • 벤더가 채용하는 전략
  • 주요 산업 전략
  • 계층 분석 : 2023 vs 2032

제4장 말 헬스케어 시장 : 거시적 분석과 시장 역학

  • 서론
  • 세계의 말 헬스케어 시장 금액 2022-2032
  • 시장 역학
    • 시장 성장 촉진요인
    • 시장 성장 억제요인
    • 주요 과제
    • 주요 기회
  • 성장 촉진요인과 억제요인의 영향 분석
  • See-Saw 분석
  • Porter's Five Forces 모델
    • 구매자의 교섭력
    • 구매자의 교섭력
    • 대체품의 위협
    • 신규 참여업체의 위협
    • 경쟁 기업 간의 경쟁 관계
  • PESTEL 분석
    • 정치적 상황
    • 경제 상황
    • 테크놀러지 상황
    • 법적 상황
    • 사회적 상황

제5장 말 헬스케어 시장 : 제품별 2022-2032

  • 시장 개요
  • 성장·매출 분석 : 2023 vs 2032
  • 수량과 가격 분석2022-2032
  • 시장 세분화
    • 백신
    • 의약품
      • 구충제
      • 항감염제
      • 항염증제와 진통제
      • 기타 의약품
    • 약용 사료첨가물
    • 진단
    • 소프트웨어와 서비스
    • 기타

제6장 말 헬스케어 시장 : 적응증별 2022-2032

  • 시장 개요
  • 성장·매출 분석 : 2023 vs 2032
  • 수량과 가격 분석2022-2032
  • 시장 세분화
    • 근골격계 질환
    • 기생충 방제
    • 내과
    • 말 헤르페스 바이러스
    • 말 뇌척수염
    • 말 인플루엔자
    • 웨스트 나일 바이러스
    • 파상풍
    • 기타

제7장 말 헬스케어 시장 : 액티비티별 2022-2032

  • 시장 개요
  • 성장·매출 분석 : 2023 vs 2032
  • 수량과 가격 분석2022-2032
  • 시장 세분화
    • 스포츠/레이스
    • 레크리에이션
    • 기타

제8장 말 헬스케어 시장 : 유통 채널별 2022-2032

  • 시장 개요
  • 성장·매출 분석 : 2023 vs 2032
  • 수량과 가격 분석2022-2032
  • 시장 세분화
    • 동물 병원과 클리닉
    • E-Commerce
    • 기타

제9장 북미의 말 헬스케어 시장 2022-2032

  • 시장 개요
  • 말 헬스케어 시장 : 제품별 2022-2032
  • 말 헬스케어 시장 : 적응증별 2022-2032
  • 말 헬스케어 시장 : 액티비티별 2022-2032
  • 말 헬스케어 시장 : 유통 채널별 2022-2032
  • 말 헬스케어 시장 : 지역별 2022-2032
    • 북미
      • 미국
      • 캐나다
      • 기타 북미

제10장 영국과 유럽연합의 말 헬스케어 시장 2022-2032

  • 시장 개요
  • 말 헬스케어 시장 : 제품별 2022-2032
  • 말 헬스케어 시장 : 적응증별 2022-2032
  • 말 헬스케어 시장 : 액티비티별 2022-2032
  • 말 헬스케어 시장 : 유통 채널별 2022-2032
  • 말 헬스케어 시장 : 지역별 2022-2032
    • 영국과 유럽연합
      • 영국
      • 독일
      • 스페인
      • 이탈리아
      • 프랑스
      • 기타 유럽

제11장 아시아태평양의 말 헬스케어 시장 2022-2032

  • 시장 개요
  • 말 헬스케어 시장 : 제품별 2022-2032
  • 말 헬스케어 시장 : 적응증별 2022-2032
  • 말 헬스케어 시장 : 액티비티별 2022-2032
  • 말 헬스케어 시장 : 유통 채널별 2022-2032
  • 말 헬스케어 시장 : 지역별 2022-2032
    • 아시아태평양
      • 중국
      • 일본
      • 인도
      • 호주
      • 한국
      • 기타 아시아태평양

제12장 라틴아메리카의 말 헬스케어 시장 2022-2032

  • 시장 개요
  • 말 헬스케어 시장 : 제품별 2022-2032
  • 말 헬스케어 시장 : 적응증별 2022-2032
  • 말 헬스케어 시장 : 액티비티별 2022-2032
  • 말 헬스케어 시장 : 유통 채널별 2022-2032
  • 말 헬스케어 시장 : 지역별 2022-2032
    • 라틴아메리카
      • 브라질
      • 멕시코
      • 기타 라틴아메리카

제13장 중동 및 아프리카의 말 헬스케어 시장 2022-2032

  • 시장 개요
  • 말 헬스케어 시장 : 제품별 2022-2032
  • 말 헬스케어 시장 : 적응증별 2022-2032
  • 말 헬스케어 시장 : 액티비티별 2022-2032
  • 말 헬스케어 시장 : 유통 채널별 2022-2032
  • 말 헬스케어 시장 : 지역별 2022-2032
    • 중동 및 아프리카
      • GCC
      • 아프리카
      • 기타 중동 및 아프리카

제14장 기업 개요

  • Zoetis Inc.
  • Boehringer Ingelheim
  • Merck & Co.
  • Ceva
  • Sound
  • Hallmarq Veterinary Imaging
  • Esaote SPA
  • Vetoquinol S.A.
  • IDEXX Laboratories Inc.
  • Dechra Pharmaceuticals PLC
  • 기타 주요 기업
ksm 24.02.19

The equine healthcare market is expected to grow at a CAGR of 6.1% during the forecast period of 2024 to 2032, driven by key drivers such as preventive healthcare measures, advancements in diagnostics and treatment, and the rising focus on equine sports and recreation. However, challenges related to cost and accessibility pose constraints. Market segmentation underscores the dominance of specific product categories and indications, while geographic trends highlight regional variations in market dynamics. The competitive landscape emphasizes the strategic efforts of key players to navigate this dynamic market and capitalize on emerging opportunities. As the industry evolves, addressing accessibility issues and fostering innovation will be crucial for sustained success in the equine healthcare market.

Increasing Emphasis on Preventive Healthcare

The equine healthcare market is experiencing a notable boost due to the rising emphasis on preventive healthcare measures for horses. Horse owners and caretakers are increasingly recognizing the importance of vaccines and medicinal feed additives to prevent diseases and maintain the overall health of equines. This trend is evidenced by a substantial increase in the adoption of preventive healthcare practices in the equine community.

Advancements in Diagnostics and Treatment

Advancements in equine diagnostics and pharmaceuticals have significantly contributed to the market's growth. The development of sophisticated diagnostic tools and effective pharmaceuticals for musculoskeletal disorders, internal medicine, and viral infections like Equine Herpes Virus and Equine Influenza has enhanced the ability to diagnose and treat various health conditions in horses. This trend is substantiated by the increasing use of advanced diagnostics and pharmaceuticals in equine veterinary practices.

Rising Focus on Equine Sports and Recreation

The growing popularity of equine sports and recreational activities is driving the demand for healthcare products and services tailored to the unique needs of performance horses. This includes specialized treatments for musculoskeletal disorders and parasite control, as well as the adoption of software and services for comprehensive healthcare management. The increasing engagement of horses in various competitive and leisure activities is a key driver influencing market dynamics.

Market Restraint

Despite the positive trends, the equine healthcare market faces a notable restraint related to cost and accessibility. The high cost of advanced diagnostics, pharmaceuticals, and specialized healthcare services poses a challenge for horse owners, especially in regions where accessibility to equine healthcare resources is limited. This constraint hinders the widespread adoption of advanced healthcare solutions in certain segments of the equine community.

Market Analysis by Product: Pharmaceuticals Dominate the Market

The equine healthcare market is segmented into vaccines, pharmaceuticals, medicinal feed additives, diagnostics, software & services, and others. In 2023, the highest revenue was generated by pharmaceuticals, driven by the demand for effective treatments for various equine health conditions. However, the highest CAGR during the forecast period (2024-2032) is expected in the software & services segment, as equine healthcare management systems gain traction and become integral to overall equine welfare.

Market Segmentation by Indication: Musculoskeletal Disorders and Parasite Control Dominate the Market

The indication-based segmentation includes musculoskeletal disorders, parasite control, internal medicine, Equine Herpes Virus, Equine Encephalomyelitis, Equine Influenza, West Nile Virus, Tetanus, and others. In 2023, musculoskeletal disorders and parasite control recorded the highest revenue, reflecting the prevalent health concerns among horses. However, the highest CAGR during the forecast period is expected in the Equine Herpes Virus and Equine Influenza segments, indicating a shifting landscape of health priorities in the equine community.

North America Remains the Global Leader

The equine healthcare market exhibits diverse geographic trends, with varying revenue contributions and CAGR across regions. North America emerged as the region with the highest revenue in 2023, driven by a well-established equine industry and a high level of awareness regarding equine healthcare. However, the region with the highest CAGR during the forecast period is anticipated to be Asia-Pacific, reflecting a growing interest in equine sports and recreation and an increasing focus on equine health in this region.

Market Competition to Intensify during the Forecast Period

The equine healthcare market features intense competition among key players, including Zoetis Inc., Boehringer Ingelheim, Merck & Co., Ceva, Sound, Hallmarq Veterinary Imaging, Esaote SPA, Vetoquinol S.A., IDEXX Laboratories, Inc., Dechra Pharmaceuticals PLC, and others. These companies employ strategies such as product innovation, collaborations, and acquisitions to strengthen their market position. In 2023, the total market revenues for these players were [provide actual revenue figures], with an expected increase during the forecast period from 2024 to 2032.

Historical & Forecast Period

This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2023 to 2031.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation ofEquine Healthcare market are as follows:

  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Equine Healthcare market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Product

    • Vaccines
    • Pharmaceuticals
  • Parasiticides
  • Anti-infectives
  • Anti-inflammatory & Analgesics
  • Other Pharmaceuticals
    • Medicinal Feed Additives
    • Diagnostics
    • Software & Services
    • Others

Indication

    • Musculoskeletal Disorders
    • Parasite Control
    • Internal Medicine
    • Equine Herpes Virus
    • Equine Encephalomyelitis
    • Equine Influenza
    • West Nile Virus
    • Tetanus
    • Others

Activity

    • Sports/Racing
    • Recreation
    • Others

Distribution Channel

    • Veterinary Hospitals & Clinics
    • E-commerce
    • Others

Region Segment (2021-2031; US$ Million)

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • UK and European Union
    • UK
    • Germany
    • Spain
    • Italy
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Key questions answered in this report:

  • What are the key micro and macro environmental factors that are impacting the growth of Equine Healthcare market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2031.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Equine Healthcare market?
  • Which is the largest regional market for Equine Healthcare market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Equine Healthcare market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Equine Healthcare market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Equine Healthcare Market
  • 2.2. Global Equine Healthcare Market, By Product, 2023 (US$ Million)
  • 2.3. Global Equine Healthcare Market, By Indication, 2023 (US$ Million)
  • 2.4. Global Equine Healthcare Market, By Activity, 2023 (US$ Million)
  • 2.5. Global Equine Healthcare Market, By Distribution Channel, 2023 (US$ Million)
  • 2.6. Global Equine Healthcare Market, By Geography, 2023 (US$ Million)
  • 2.7. Attractive Investment Proposition by Geography, 2023

3. Equine Healthcare Market: Competitive Analysis

  • 3.1. Market Positioning of Key Equine Healthcare Market Vendors
  • 3.2. Strategies Adopted by Equine Healthcare Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2023 Versus 2032

4. Equine Healthcare Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Equine Healthcare Market Value, 2022 - 2032, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis
  • 4.6. Porter's Five Force Model
    • 4.6.1. Supplier Power
    • 4.6.2. Buyer Power
    • 4.6.3. Threat Of Substitutes
    • 4.6.4. Threat Of New Entrants
    • 4.6.5. Competitive Rivalry
  • 4.7. PESTEL Analysis
    • 4.7.1. Political Landscape
    • 4.7.2. Economic Landscape
    • 4.7.3. Technology Landscape
    • 4.7.4. Legal Landscape
    • 4.7.5. Social Landscape

5. Equine Healthcare Market: By Product, 2022-2032, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2023 Versus 2032
  • 5.3. Volume and Pricing Analysis, 2022-2032
  • 5.4. Market Segmentation
    • 5.4.1. Vaccines
    • 5.4.2. Pharmaceuticals
      • 5.4.2.1. Parasiticides
      • 5.4.2.2. Anti-infectives
      • 5.4.2.3. Anti-inflammatory & Analgesics
      • 5.4.2.4. Other Pharmaceuticals
    • 5.4.3. Medicinal Feed Additives
    • 5.4.4. Diagnostics
    • 5.4.5. Software & Services
    • 5.4.6. Others

6. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2023 Versus 2032
  • 6.3. Volume and Pricing Analysis, 2022-2032
  • 6.4. Market Segmentation
    • 6.4.1. Musculoskeletal Disorders
    • 6.4.2. Parasite Control
    • 6.4.3. Internal Medicine
    • 6.4.4. Equine Herpes Virus
    • 6.4.5. Equine Encephalomyelitis
    • 6.4.6. Equine Influenza
    • 6.4.7. West Nile Virus
    • 6.4.8. Tetanus
    • 6.4.9. Others

7. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)

  • 7.1. Market Overview
  • 7.2. Growth & Revenue Analysis: 2023 Versus 2032
  • 7.3. Volume and Pricing Analysis, 2022-2032
  • 7.4. Market Segmentation
    • 7.4.1. Sports/Racing
    • 7.4.2. Recreation
    • 7.4.3. Others

8. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)

  • 8.1. Market Overview
  • 8.2. Growth & Revenue Analysis: 2023 Versus 2032
  • 8.3. Volume and Pricing Analysis, 2022-2032
  • 8.4. Market Segmentation
    • 8.4.1. Veterinary Hospitals & Clinics
    • 8.4.2. E-commerce
    • 8.4.3. Others

9. North America Equine Healthcare Market, 2022-2032, USD (Million)

  • 9.1. Market Overview
  • 9.2. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
  • 9.3. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
  • 9.4. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
  • 9.5. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
  • 9.6.Equine Healthcare Market: By Region, 2022-2032, USD (Million)
    • 9.6.1.North America
      • 9.6.1.1. U.S.
        • 9.6.1.1.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
        • 9.6.1.1.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
        • 9.6.1.1.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
        • 9.6.1.1.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
      • 9.6.1.2. Canada
        • 9.6.1.2.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
        • 9.6.1.2.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
        • 9.6.1.2.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
        • 9.6.1.2.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
      • 9.6.1.3. Rest of North America
        • 9.6.1.3.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
        • 9.6.1.3.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
        • 9.6.1.3.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
        • 9.6.1.3.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)

10. UK and European Union Equine Healthcare Market, 2022-2032, USD (Million)

  • 10.1. Market Overview
  • 10.2. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
  • 10.3. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
  • 10.4. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
  • 10.5. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
  • 10.6.Equine Healthcare Market: By Region, 2022-2032, USD (Million)
    • 10.6.1.UK and European Union
      • 10.6.1.1. UK
        • 10.6.1.1.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
        • 10.6.1.1.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
        • 10.6.1.1.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
        • 10.6.1.1.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
      • 10.6.1.2. Germany
        • 10.6.1.2.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
        • 10.6.1.2.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
        • 10.6.1.2.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
        • 10.6.1.2.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
      • 10.6.1.3. Spain
        • 10.6.1.3.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
        • 10.6.1.3.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
        • 10.6.1.3.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
        • 10.6.1.3.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
      • 10.6.1.4. Italy
        • 10.6.1.4.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
        • 10.6.1.4.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
        • 10.6.1.4.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
        • 10.6.1.4.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
      • 10.6.1.5. France
        • 10.6.1.5.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
        • 10.6.1.5.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
        • 10.6.1.5.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
        • 10.6.1.5.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
      • 10.6.1.6. Rest of Europe
        • 10.6.1.6.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
        • 10.6.1.6.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
        • 10.6.1.6.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
        • 10.6.1.6.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)

11. Asia Pacific Equine Healthcare Market, 2022-2032, USD (Million)

  • 11.1. Market Overview
  • 11.2. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
  • 11.3. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
  • 11.4. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
  • 11.5. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
  • 11.6.Equine Healthcare Market: By Region, 2022-2032, USD (Million)
    • 11.6.1.Asia Pacific
      • 11.6.1.1. China
        • 11.6.1.1.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
        • 11.6.1.1.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
        • 11.6.1.1.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
        • 11.6.1.1.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
      • 11.6.1.2. Japan
        • 11.6.1.2.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
        • 11.6.1.2.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
        • 11.6.1.2.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
        • 11.6.1.2.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
      • 11.6.1.3. India
        • 11.6.1.3.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
        • 11.6.1.3.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
        • 11.6.1.3.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
        • 11.6.1.3.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
      • 11.6.1.4. Australia
        • 11.6.1.4.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
        • 11.6.1.4.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
        • 11.6.1.4.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
        • 11.6.1.4.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
      • 11.6.1.5. South Korea
        • 11.6.1.5.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
        • 11.6.1.5.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
        • 11.6.1.5.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
        • 11.6.1.5.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
      • 11.6.1.6. Rest of Asia Pacific
        • 11.6.1.6.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
        • 11.6.1.6.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
        • 11.6.1.6.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
        • 11.6.1.6.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)

12. Latin America Equine Healthcare Market, 2022-2032, USD (Million)

  • 12.1. Market Overview
  • 12.2. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
  • 12.3. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
  • 12.4. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
  • 12.5. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
  • 12.6.Equine Healthcare Market: By Region, 2022-2032, USD (Million)
    • 12.6.1.Latin America
      • 12.6.1.1. Brazil
        • 12.6.1.1.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
        • 12.6.1.1.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
        • 12.6.1.1.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
        • 12.6.1.1.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
      • 12.6.1.2. Mexico
        • 12.6.1.2.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
        • 12.6.1.2.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
        • 12.6.1.2.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
        • 12.6.1.2.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
      • 12.6.1.3. Rest of Latin America
        • 12.6.1.3.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
        • 12.6.1.3.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
        • 12.6.1.3.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
        • 12.6.1.3.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)

13. Middle East and Africa Equine Healthcare Market, 2022-2032, USD (Million)

  • 13.1. Market Overview
  • 13.2. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
  • 13.3. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
  • 13.4. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
  • 13.5. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
  • 13.6.Equine Healthcare Market: By Region, 2022-2032, USD (Million)
    • 13.6.1.Middle East and Africa
      • 13.6.1.1. GCC
        • 13.6.1.1.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
        • 13.6.1.1.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
        • 13.6.1.1.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
        • 13.6.1.1.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
      • 13.6.1.2. Africa
        • 13.6.1.2.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
        • 13.6.1.2.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
        • 13.6.1.2.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
        • 13.6.1.2.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
      • 13.6.1.3. Rest of Middle East and Africa
        • 13.6.1.3.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
        • 13.6.1.3.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
        • 13.6.1.3.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
        • 13.6.1.3.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)

14. Company Profile

  • 14.1. Zoetis Inc.
    • 14.1.1. Company Overview
    • 14.1.2. Financial Performance
    • 14.1.3. Product Portfolio
    • 14.1.4. Strategic Initiatives
  • 14.2. Boehringer Ingelheim
    • 14.2.1. Company Overview
    • 14.2.2. Financial Performance
    • 14.2.3. Product Portfolio
    • 14.2.4. Strategic Initiatives
  • 14.3. Merck & Co.
    • 14.3.1. Company Overview
    • 14.3.2. Financial Performance
    • 14.3.3. Product Portfolio
    • 14.3.4. Strategic Initiatives
  • 14.4. Ceva
    • 14.4.1. Company Overview
    • 14.4.2. Financial Performance
    • 14.4.3. Product Portfolio
    • 14.4.4. Strategic Initiatives
  • 14.5. Sound
    • 14.5.1. Company Overview
    • 14.5.2. Financial Performance
    • 14.5.3. Product Portfolio
    • 14.5.4. Strategic Initiatives
  • 14.6. Hallmarq Veterinary Imaging
    • 14.6.1. Company Overview
    • 14.6.2. Financial Performance
    • 14.6.3. Product Portfolio
    • 14.6.4. Strategic Initiatives
  • 14.7. Esaote SPA
    • 14.7.1. Company Overview
    • 14.7.2. Financial Performance
    • 14.7.3. Product Portfolio
    • 14.7.4. Strategic Initiatives
  • 14.8. Vetoquinol S.A.
    • 14.8.1. Company Overview
    • 14.8.2. Financial Performance
    • 14.8.3. Product Portfolio
    • 14.8.4. Strategic Initiatives
  • 14.9. IDEXX Laboratories, Inc.
    • 14.9.1. Company Overview
    • 14.9.2. Financial Performance
    • 14.9.3. Product Portfolio
    • 14.9.4. Strategic Initiatives
  • 14.10. Dechra Pharmaceuticals PLC
    • 14.10.1. Company Overview
    • 14.10.2. Financial Performance
    • 14.10.3. Product Portfolio
    • 14.10.4. Strategic Initiatives
  • 14.11. Other Notable Players
    • 14.11.1. Company Overview
    • 14.11.2. Financial Performance
    • 14.11.3. Product Portfolio
    • 14.11.4. Strategic Initiatives
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제